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ioux Falls, South Dakota
massive natural experiment is under way in Japan that
ay generate important information regarding the relation-
hips between life-style factors—diet, smoking, stress—and
ardiovascular disease (1). Since the end of World War II,
generation of Japanese men and women who have been
ssimilating a more Western dietary pattern is reaching the
ge where, at least in the West, coronary heart disease
CHD) typically begins to take its toll. Is the adoption of a
igher-fat, higher-calorie Western diet going to result in a
reater prevalence of classic CHD risk factors, such as
ncreased serum cholesterol and blood pressure, in Japan? Is
HD going to precipitously rise in Japan? A cohort of
ost-World War II Japanese men have been followed by
ekikawa et al. (2) and have been found to have similar
ifetime cholesterol and blood pressure levels as white men
n the U.S., along with a greater rate of smoking and
revalence of diabetes. So, the stage appears to be set.
owever, to date, CHD rates in Japan remain less than
ne-half of those in the U.S. (3). This unexpected finding
as stimulated the search for a factor or factors in the
apanese diet or life-style that have the power to withstand
he onslaught of advancing risk factors. In this issue of the
ournal, Sekikawa et al. (4) tested a hypothesis that is
aining traction around the world, one that might find its
ost compelling confirmation in Japan: could the factor be
mega-3 fatty acids?
See page 417
Sekikawa et al. (4) measured serum omega-3 fatty acids
evels, carotid intimal-medial thickness (IMT), and coro-
ary artery calcium (CAC) burden in approximately 900
Editorials published in the Journal of the American College of Cardiology reflect the
iews of the authors and do not necessarily represent the views of JACC or the
merican College of Cardiology.
From the Sanford Research/USD, Metabolism and Nutrition Research Center,
ioux Falls, South Dakota. Dr. Harris is a scientific advisor and speaker for
laxoSmithKline (who now market Lovaza, the prescription omega-3), and he is an
dvisor to and grant recipient from Monsanto, Co., which is currently developing a
oybean-based omega-3-enriched oil. In other words, his generally kind words for thec
omega-3 hypothesis,” which he believes to be evidence-based, could be construed as
eing conditioned by his relations with these companies.en; one-third were Japanese men living in Japan (JiJ),
ne-third were Japanese-American men living in Honolulu
JiA), and the final one-third were white men residing in the
.S. (W). The researchers made several observations. First,
erum omega-3 levels were 45% to 80% greater in JiJ than in
iA or W, respectively, indicating that the diet of the JiA
ohort had, like their ancestors, migrated east. Second, both
arotid IMT and CAC were reduced in the JiJ compared
ith both the W and the JiA groups but, unexpectedly,
ommon carotid plaque burden was similar in the former 2
roups but increased in the latter. This finding illustrates
ow carotid plaque burden and carotid IMT can dissociate.
n the 2 low-omega-3 populations (W and JiA), there were
o relationships between any vascular measure and serum
mega-3 fatty acid levels but, in the JiJ group (where the
mega-3 range was the greatest), there was a significant
nverse relationship between carotid IMT and serum
mega-3 levels. However, CAC burdens were not related to
mega-3 status in any cohort (another disconnect between
hese 2 surrogates of atherosclerosis). Finally, the differences
etween carotid IMT and CAC in the JiJ and the W
opulations (which persisted after adjustment for classical
HD risk factors) disappeared when adjusted for serum
mega-3 content. This observation suggests that low
mega-3 levels may be in the causal pathway for carotid
MT and CAC. The authors conclude that “very high
ntake of marine-derived n-3 fatty acids has antiatheroscle-
otic effects.” The Japanese consume between 8 and 15
imes more eicosapentaenoic acid (EPA) and docosahexae-
oic acid (DHA) than typical Westerners (0.8 to 1.5 g/day)
5,6). Although there are other factors in the Japanese diet
hat could play a role in this phenomenon (e.g., low-fat
iets, soy proteins, and/or isoflavones), the power of
mega-3 levels to eliminate cross-population disparities
uggests that these may be responsible.
nuit experience. But is a “very high intake of n-3 fatty
cids” always cardioprotective? Can these findings be gen-
ralized to others? Omega-3 intakes in Japan are only one-
uarter of those in Eskimos (7), the population that birthed
he omega-3 hypothesis. More than 30 years ago, Dyerberg
nd Bang (8) reported, despite the consumption of a diet
ery low in fruits, vegetables, and complex carbohydrates
nd high in fat and cholesterol, that serum cholesterol and
riglycerides were lower in Greenland Inuit than in age-
atched Danes. Kromann and Green (9) reported that
cute myocardial infarction rates in this same population
ere markedly lower than those in Denmark. Through a
eries of now-classic investigations, the “Eskimo factor” that
pparently protected them from the ravages of CHD was
roposed to be the omega-3 fatty acids (EPA and DHA)
10) provided by the whale, seal, and fish consumed as part
f their traditional diet. The seeds planted by these inves-
igators took many years to germinate, sprout, and grow and
re finally coming into full bloom. Seminal randomized
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Editorial Comment August 5, 2008:425–711), the 1999 Gruppo Italiano per lo Studio della Soprav-
ivenza nell’Infarto Miocardico (GISSI) Prevenzione study
12), and the 2007 Japan EPA Lipid Intervention Study
13) have all confirmed that increased intakes of EPA alone
r EPADHA reduce the risk for CHD. More and more,
ational and international health organizations are estab-
ishing recommendations for both primary and secondary
revention of CHD that include EPA and DHA (14).
But all is not well in the far north. Although some
nvestigators continue to report that Inuit consuming tradi-
ional diets have lower CHD rates (15–17), others are
uestioning this dogma (18). Recent evidence from the
OCADAN (Genetics of Coronary Artery Disease in
laska Natives) study indicates that carotid atherosclerosis
s not only unrelated to omega-3 fatty acid intakes in this
ohort (19) but, surprisingly, its prevalence is now greater
han that in U.S. white populations (20). At least part of the
roblem in Alaska appears to be not a lack of omega-3 but
he introduction of massive amounts of shortenings and
ther saturated fats into their Westernizing diet (18).
aturated and monounsaturated fat intakes in GOCADAN
re approximately 12% and 15% of energy, whereas in a
imilar age group in Japan, intakes are 8% and 9.4% of
nergy, respectively (6). This difference may be critical.
orway? The Inuit population is not the only one consum-
ng relatively high amounts of omega-3 fatty acids that still
evelops CHD. The prevalence of carotid plaque and
ntimal thickening is at “Western” levels in Norway as well
21), a country where the omega-3 intake is approximately
g/day in men (22), which is similar to that in Japan.
upplementation of elderly, hyperlipidemic Norwegian men
ith omega-3 fatty acids (2.4 g/day) did not reduce carotid
laque burden or carotid IMT over the course of 3 years, but
t did improve pulse wave velocity, a marker of arterial
lasticity (23). Interestingly, the fat intake of Norwegian
oronary patients (13% energy saturated and 12% mono-
nsaturated fatty acids) (22) is reminiscent of the Inuit
ntake and considerably greater than that in Japan.
The Japanese experience, when contrasted to that of the
nuit and the Norwegians, suggests that the cardioprotective
unch of the long chain omega-3 fatty acids may be no
atch for diets high in fat, particularly saturated fat. Even
igher-than-Inuit intakes of omega-3 have been tested for
heir ability to slow or reverse coronary artery atherosclerosis
nd were found wanting. Sacks et al. (24) randomized 59
atients in the U.S. to 6 g of EPA  DHA and followed
hem for 28 months and found no evidence for slowed
rogression measured by quantitative coronary angiography.
n the other hand, a prolonged (lifetime?) above-average
ietary intake of omega-3 FAs may be able to accomplish
hat a relatively short-term high-dose intervention could
ot. In 233 women participating in the Estrogen Replace-
ent and Atherosclerosis study, those with higher than the
edian levels of DHA in serum phospholipids experienced
slower progression of coronary artery disease over 3.2 yearshan women with lower levels (25). These findings suggesthe not unreasonable hypothesis that decades of a moder-
tely high omega-3 dietary intake may be the best way to
low atherosclerosis. The observations of Sekikawa et al. (4)
armonize with this view and strongly suggest that the
Japanese factor” is likely to be omega-3 fatty acids. Only
ime will tell how this natural experiment will turn out, but
ith the incessant intrusion of Western dietary ways into
apan, one cannot be particularly optimistic.
eprint requests and correspondence: Dr. William Harris,
anford Research/USD, 1100 East 21st Street, Suite 700, Sioux
alls, South Dakota 57105. E-mail: bill.harris@usd.edu.
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